You are now leaving this site.
Any third-party link you select from this site may take you to an Exact Sciences website intended for US audiences or a website that is not affiliated with Exact Sciences.
Choose your country or region:
11 December 2020
RxPONDER: Even more women may forgo chemo for breast cancer
10 December 2020
We respond to RxPONDER trial results that suggest postmenopausal women with early-stage BC/low recurrence score could skip adjuvant chemo
9 December 2020
Postmenopausal women with early-stage BC/low recurrence score could skip adjuvant chemo
24 September 2020
Oncotype DX® Test Predicts Chemotherapy Benefit
17 September 2020
How Coronavirus Has Affected Breast Cancer Diagnosis and Treatment
20 December 2019
Gene Tests to Help Breast Cancer Patients
16 October 2019
Do I Need Chemotherapy?
3 September 2019
Genomic Testing Helps Women to Tailor Their Breast Cancer Care
31 July 2019
Scottish Government to Respond to NHS Tayside Chemo Criticism in Coming Weeks
30 April 2019
Top Doctors to Help with Cancer Review at NHS Tayside
17 April 2019
NHS Tayside Chemotherapy Treatment Probe Calls for Review of Decision Making Across Health Board
23 March 2019
5,000 Breast Cancer Sufferers Could be Spared Chemotherapy if Offered Gene Testing, Study Suggests
27 February 2019
Understanding the Patient as Well as the Disease Is the Only Way to Make the NHS More Sustainable
19 December 2018
NICE Expands Recommendation for the Oncotype DX Test to More Patients with Early-stage Breast Cancer
22 October, 2018
New Real-world Evidence Confirms Value of the Oncotype DX Test in Clinical Practice for Patients with Early-stage Breast Cancer
29 December 2018
NICE Publishes Updated Guidance with Expanded Recommendation for Oncotype DX
29 July 2018
HEALTH: An Exciting Breakthrough in Breast Cancer Treatment
3 June 2018
Landmark Breast Cancer Study Spares Women from Chemotherapy
3 June 2018
Thousands of Breast Cancer Patients Could Avoid Chemo, Study Finds
3 June 2018
Breast Cancer: Test Means Fewer Women Will Need Chemotherapy
11 September 2017
Genomic Test Shows that Half of Under-40s with Early Breast Cancer Have Excellent Prognosis Despite not Having Chemotherapy Treatment
13 June 2017
New Data Show Important Role of Genomic Testing in Treatment of Older Breast Cancer Patients
20 March 2017
Genomic Health’s Oncotype DX Breast Cancer Test Can Significantly Improve Patient Outcomes for Node-positive Patients, International Studies Reveal
6 February 2017
NHS Adoption of Oncotype DX Test Leads to Substantial Reduction in Unnecessary Chemotherapy for UK Breast Cancer Patients
6 December 2017
Deciding on Chemotherapy
1 October 2017
Breast Cancer Test: New Technique Could Spare Thousands from Chemotherapy
10 October 2016
Large Study Shows Older Breast Cancer Patients Have Worse Outcomes
20 June 2016
Updated NICE Quality Standard Recommends Oncotype DX® in Early-stage Breast Cancer
9 October 2016
Women Diagnosed with Breast Cancer After 70 Twice as Likely to Die from It
5 February 2015
Breast Cancer Test to Spare Thousands from Chemotherapy: Pioneering Treatment to Be Available on the NHS from April
© Exact Sciences UK, Ltd.
Suite 1 - Scott House
The Concourse
Waterloo Station
LONDON, SE1 7LY
Contact Us
Any third-party link you select from this site may take you to an Exact Sciences website intended for US audiences or a website that is not affiliated with Exact Sciences.